Oleś Krzysztof, Składzień Jacek, Szczepański Wojciech, Okoń Krzysztof, Leszczyńska Joanna, Bojanowska Emilia, Bartuś Krzysztof, Mika Joanna
Department of Otolaryngology, Medical College Jagiellonian University, Cracow, Poland.
Department of Pathomorphology, Medical College Jagiellonian University, Cracow, Poland.
Med Sci Monit. 2015 Apr 10;21:1043-50. doi: 10.12659/MSM.893043.
MALT lymphomas were classified for differential diagnostics of IgG4-dependent disease due to their exceptional predilection to intraorbital localization. Therefore, the goal of our studies was large retrospective analysis of patients diagnosed with MALT lymphomas within the orbital tissues, since no such studies have been conducted in Poland.
MATERIAL/METHODS: The starting study population consisted of 167 patients with isolated infiltrative tumor diseases within the orbital region treated at the Department of Otolaryngology, Head and Neck Surgery of the Medical College Jagiellonian University in Cracow. The immunohistochemical assays using anti-IgG, anti-IgG4 and anti-CD138 antibodies were used to estimate the IgG4+/CD138+ and IgG4+/IgG+ ratios.
Of all the studied and analyzed patients, a final group of 19 patients with orbital MALT lymphomas was selected to undergo diagnostic examinations for IgG4-related disease. Detailed analysis and diagnostic screening for IgG4-related disease was performed and results meeting the criteria of IgG4-dependent disease were obtained in 10 out of 19 patients with the diagnosis of MALT tumor established on the basis of immunohistochemical assays.
MALT lymphomas are the most common of all lymphomas occurring within orbital tissues. In this study, results consistent with the criteria of IgG4-related disease were obtained in approximately 50% patients with immunohistochemical diagnosis of orbital MALT lymphoma.
黏膜相关淋巴组织(MALT)淋巴瘤因其特别易发生于眶内,故被纳入IgG4相关性疾病的鉴别诊断。因此,我们研究的目的是对波兰尚未开展的眶内组织诊断为MALT淋巴瘤的患者进行大规模回顾性分析。
材料/方法:起始研究人群包括167例在克拉科夫雅盖隆大学医学院耳鼻咽喉头颈外科接受治疗的眶区孤立性浸润性肿瘤疾病患者。使用抗IgG、抗IgG4和抗CD138抗体的免疫组织化学检测来评估IgG4+/CD138+和IgG4+/IgG+比值。
在所有研究和分析的患者中,最终选出19例眶内MALT淋巴瘤患者进行IgG4相关疾病的诊断检查。对IgG4相关疾病进行了详细分析和诊断筛查,在19例经免疫组织化学检测确诊为MALT肿瘤的患者中,有10例获得了符合IgG4相关性疾病标准的结果。
MALT淋巴瘤是眶内组织中所有淋巴瘤中最常见的。在本研究中,约50%经免疫组织化学诊断为眶内MALT淋巴瘤的患者获得了与IgG4相关疾病标准一致的结果。